Lanthanum carbonate (LaC) is used to prevent hyperphosphatemia in dialysis patients. It is commonly believed that there is little LaC absorption from the intestines. However, La deposition in the gastric mucosa, which we coined "gastric lanthanosis", was recently reported. We describe here the clinicopathological features of and a possible mechanism for gastric lanthanosis. This study included 23 patients with definite gastric lanthanosis. We extracted characteristic clinicopathological features of gastric lanthanosis by computed tomography (CT) imaging and endoscopic, histologic, electron-microscopic, and element analysis examinations. The Helicobacter pylori infection rate in the lanthanosis group was much lower than that among the general population. The clinicopathological features characteristic of gastric lanthanosis were mucosal high-density linear appearance by CT, reflective brightwhite spots (BWS) by gastroscopy, eosinophilic histiocytes occasionally phagocytizing foreign materials by histology, and numerous electron-dense particles in the histiocytes. The particles had burr-like skeletons resembling La crystals. Gastric lanthanosis is an under-reported, but not a rare lesion. It is characterized by endoscopic BWS and histologic eosinophilic histiocytes in dialysis patients treated with LaC. The proposed mechanism for gastric lanthanosis is that LaC is dissolved by gastric juice, crystallized within the mucosa and is phagocytized by histiocytes.
Lanthanum carbonate (LaC), a non-aluminum and noncalcium phosphate binder, is used to prevent hyperphosphatemia in dialysis patients. 1, 2 LaC binds with dietary phosphorus in the gastrointestinal tract and interrupts mucosal absorption. 2, 3 It is commonly believed that there is minimal absorption of LaC into the gastrointestinal mucosa; therefore, its use in clinical practice does not cause organ failure. However lanthanum (La) deposition in the liver and bone has been reported in animal experiments. 2, 4 Contrary to conventional wisdom, there have been several reports of La deposition in the human gastric mucosa of dialysis patients treated with LaC since 2015. [5] [6] [7] [8] [9] [10] [11] [12] In 2009, an autopsy report of a case of nephrogenic systemic fibrosis with La deposition in the mesenteric lymph nodes was published, but findings in the stomach were not described. 13 This under-reported lesion has not been comprehensively investigated, and the clinical significance and mechanism remains unclear.
In this study, we named this condition "gastric lanthanosis" and comprehensively examined 23 cases of gastric lanthanosis to evaluate the clinicopathological feature and describe a possible mechanism by which it develops.
MATERIALS AND METHODS
This study was approved by the institutional review boards of two hospitals (Oita University Hospital and Oita Koseiren Tsurumi Hospital) and was performed in accordance with the principles stated in the Declaration of Helsinki.
between 2009 and 2015. Demographic and clinical characteristics in all 23 cases are summarized in Table 1 . The 23 cases showed common characteristic histologic and endoscopic features as described below. At the two hospitals, 38 of 126 dialysis patients treated with LaC underwent gastroscopy (GS), but showed no visible endoscopic features of gastric lanthanosis. It seems probable that they lacked La deposition, although this is not definite because histologic examination was performed in only five cases.
The following samples from lanthanosis cases were examined: 23 biopsies samples of the gastric mucosa, 3 biopsies of the duodenal mucosa, and 12 biopsies of the colorectal mucosa. In addition, one patient (Case 13 in Table 1 ) underwent gastrectomy with lymph node resection for early gastric cancer, and the resected stomach and lymph nodes were also examined.
Clinical data and CT and endoscopic examinations
We collected demographic and clinical data about patients in the 23 lanthanosis cases and in 38 cases without any visible endoscopic features of gastric lanthanosis. Data included age, sex, duration and types of dialysis, duration of LaC treatment, concurrent use of other medications, and presence or absence of digestive symptoms. All patients had taken 750 mg of LaC per day for almost the whole period, although the administration was temporarily suspended or reduced to 500 mg per day in some patients. We compared clinical data between the two groups. CT examinations were performed for 14 patients in the lanthanosis cases. The CT examinations were performed without withdrawal in our study differently from a previous report by Namie et al. 9 We divided the degrees into three grades, simplifying the classification by Namie et al., 9 that is, no findings (Grade 0), focal or slight high-density linear appearance (HD-LA) (Grade 1), or diffuse HD-LA (Grade 2), as shown in Fig. 1 . We described unusual endoscopic findings for the gastric lanthanosis and macroscopic findings for the surgically resected sample.
Histologic and immunohistochemical examinations
All biopsies and resected samples were processed into formalin-fixed paraffin-embedded blocks. Samples were prepared using hematoxylin and eosin (HE) stain, Prussian 
CT, computed tomography; HD, hemodialysis; PD, peritoneal dialysis; LaC, lanthanum carbonate; PPI, proton pump inhibitor; n.a., not available; abd., abdominal; Ant, antrum; Post, posterior wall; Less, lesser curvature blue stain, von Kossa stain, Azan-Mallory stain, and Giemsa stain for Helicobacter pylori (H. pylori). Immunohistochemical examinations were also performed using antibodies against CD68 and collagen type I (DAKO, Carpenteria, CA, USA). We mapped areas of La deposition on the resected stomach to compare the macroscopically and endoscopically abnormal areas.
Element analysis and ultrastructural examinations
An elemental analysis for La deposition in the gastric mucosa and resected lymph node of the lanthanosis cases was performed by scanning electron microscopy (SEM, S-4800, HITACHI, Tokyo, Japan), equipped with an energy dispersive X-ray microanalyzer (EDAX, Mahwah, NJ, USA). To prepare specimens for element analysis, paraffin-embedded sections were deparaffinized, fixed in 2.0% glutaraldehyde and then in 1% osmium tetroxide, and coated with gold palladium and osmium.
Ultrastructural observation was performed by transmission electron microscopy (TEM, H-7650, HITACHI) for five biopsy samples and one lymph node of the resected case according to a previously-reported method. 14 
Chemical and physical properties of LaC
We examined morphologic changes of LaC at different pH values using commercially available LaC (Fosrenol, Shire Pharmaceuticals Group Plc, Bayer, Osaka, Japan). LaC was dissolved with hydrochloric acid (HCl). By neutralizing the solution with sodium hydrate (NaOH), some sediment was precipitated. We observed the sediment by TEM as well as by light microscopy.
Statistical analysis
Statistical analysis was performed using t-tests and Chisquared tests to evaluate differences in the clinical characteristics between the two groups. The Bonferroni correction was used as multiple testing. The correction was set so that P < 0.007 was considered statistically significant.
RESULTS

Demographic and clinical characteristics in the lanthanosis
The demographic and clinical characteristics of both groups (23 and 38 cases) were compared (Table S1 ). All the clinical data had no significant differences under the multiple testing between the two groups.
Computed tomography findings
Results of the CT examinations for 14 cases of the lanthanosis revealed that 11 (79%) had a HD-LA detected in the gastric mucosa but not in the submucosa, lymph nodes, or other organs. Three cases were Grade 0, four were Grade 1, and seven were Grade 2 ( Fig. 1) . 
Endoscopic and macroscopic findings
Endoscopically, definitely unusual mucosal changes were observed and distributed throughout the stomach in all of the lanthanosis cases. (Fig. 2a) . Most of these mucosal changes were reflective, shiny, bright-white in color, and varied in size and shape: from small, flat, irregular specks to elevated plaques with granular surfaces (Fig. 2c,d) . Hereafter, we refer to these mucosal changes as brightwhite spots (BWS). In seven cases, BWS were also detected in the duodenal mucosa. These BWS were located predominantly in the duodenal bulbus and faded out in the distal portion (Fig. 2b) . These endoscopic findings were macroscopically confirmed in the resected stomach with early gastric cancer (Type 0-IIc) (Fig. 3a) .
Histologic and immunohistochemical findings
In all cases of the lanthanosis, a background of the gastric mucosa showed mild chronic inflammation. Characteristic large eosinophilic histiocytes were observed in all HE-stained samples (Fig. 4a) . Some histiocytes were multinucleated and phagocytized foreign bodies, such as transparent crystalloids and eosinophilic to brownish, coarsely to finely granular or string-like substances ( Fig. 4b) . Such a diffuse infiltrating pattern should be called histiocytosis rather than epithelioid granuloma. Histiocytic infiltration was mainly limited to the mucosa, occasionally to the lamina muscularis mucosae, but did not spill over into the submucosa. With special stains and immunohistochemical examination, calcium, collagen fibers, and hemosiderin were revealed (Fig. 4c-e) .
The mapping of areas with La-deposition in the whole resected stomach with tubular adenocarcinoma, was very informative and the macroscopic and microscopic areas with La-deposition were well matched (Fig. 3) . Small areas of La-deposition within the cancer on the map were limited to isolated non-neoplastic mucosae (Fig. 3b) . The resected lymph nodes showed sinus histiocytosis composed of similar eosinophilic histiocytes.
La deposition was not detected in all 12 colonic specimens from the lanthanosis nor in the 5 cases without any visual endoscopic features.
H. pylori was not seen with Giemsa stain in any cases of the lanthanosis. Immunohistochemically, all histiocytes were positive for CD68 (Fig. 4f) , and some phagocytized materials in the histiocytes were positive for collagen type I.
Element analysis and ultrastructural features
On SEM observation, brightly granular areas were observed probably corresponding to histiocytes (Fig. 5, inset) . By element analysis of such areas, La deposition was revealed in all cases of the lanthanosis including the resected lymph node (Fig. 5 ). Calcium and iron depositions were also detected in some cases.
On TEM observation, cytoplasm of the histiocytes was filled with numerous electron-dense substances (Fig. 6a) . The most common structures were 50 to 120 nm in diameter, round to oval particles with blurred contour, which were composed of radiated needle-shaped burr-like skeletons and flocculent material at higher magnification (Fig. 6b) . Other various structures were occasionally observed; such as aggregated lamellar spherical bodies and bead-like or fibrous substances (Fig. S1 ). Numerous similar particles were also observed in the histiocytes of the resected lymph nodes and in only one surface epithelial cell.
Chemical and physical properties of LaC
The addition of HCl to coarsely ground LaC completely dissolved it at pH 1-2. The clear solution immediately became cloudy at pH 7, by neutralizing with NaOH, and yellowish muddy sediment was precipitated (Fig. 6c) . TEM revealed that the sediment contained numerous burr-like radiated needle-shaped crystals (Fig. 6d) .
DISCUSSION
We named this under-recognized condition "gastric lanthanosis" and defined it as La deposition in the gastric mucosa of dialysis patients treated with LaC. There were several previous studies on gastric lanthanosis, but most of these were case reports from Japan. [5] [6] [7] [8] [9] [10] [11] [12] The present report is the first comprehensive study with a proposed mechanism. The 23 cases of dialysis patients treated with LaC showed the characteristic endoscopic features of the lanthanosis. The BWS in gastric lanthanosis is a distinctive endoscopic feature in its morphology and distribution. In cases with slight deposition, it may be difficult to detect BWS by endoscopic examination. However, at least in cases with BWS, LaC deposition could be certainly observed. We considered that it was very informative for clinical practice.
In this study, La deposition was detected as HD-LA on CT examination in 11 patients (79%). The positive rate in this study was higher than in a previous study (60%). 9 The difference might be due to the presence or absence of withdrawal for a week. HD-LA may be a useful screening criterion for gastric lanthanosis. The histology of gastric lanthanosis is characterized by eosinophilic histiocytes, which appear singly or in a small cluster in the early stage, and then later diffusely infiltrate the area. They are sometimes multinucleated and phagocytize foreign bodies. These histological findings are important for diagnosis of gastric lanthanosis. In general, two criteria, eosinophilic histiocytes and a history as a dialysis patient treated with LaC, seem to be sufficient for diagnosis. Element analysis by electron microscopy is required for more rigid diagnostic criteria, but it cannot be performed at every institution.
Histologic differential diagnoses include various histiocytic inflammatory conditions of the gastrointestinal tract. Gastric lanthanosis should be called histiocytosis but not granuloma, so infectious or non-infectious nodular granulomatous lesions can be excluded.
Interestingly, La deposition was not detected in neoplastic mucosa in our study. This phenomenon is reminiscent of neoplastic lesion under melanosis coli, in which neoplastic lesion is spared from pigmentation. Although details were unknown, we considered that neoplastic mucosa was malfunctioned in the mechanism of absorption.
The background of the gastric mucosa showed no histological evidence of H. pylori infection in the lanthanosis cases. This is consistent with previous reports in which H. pylori infection investigated, as only 1 of 34 cases (2.9%) was infected 7 . The prevalence of H. pylori infection is approximately 50%, irrespective of dialysis treatment, [15] [16] [17] this prevalence is unexpectedly low. Helicobacter pylori infection may prevent La deposition. The following two preventive mechanisms are possible. First, H. pylori colonize the mucus gel layer on the surface mucus cells, and produce ammonia by urease. The ammonia secretion tends to decrease the acidity of the mucus zone, and pH of there may be locally high. Consequently, La is less likely to dissolve. Second, the marked inflammatory reaction induced by H. pylori disturbs the histiocytic infiltration.
On TEM observation, the most common particles were composed of flocculent material, probably proteinous material, and burr-like skeletons resembling the crystals of La (compare Fig. 6b and d) . There have been no proposed mechanisms for the development of gastric lanthanosis. We confirmed that LaC (Fosrenol) was dissolved at pH 1-2 (the same as that of gastric juice). Thereafter, it was immediately crystalized at pH 7, which is close to that of the intestinal contents, and intracellular and extracellular fluid. In addition, the round particles were composed of flocculent proteinous material and burr-like skeletons that looked like crystals of La. Based on these findings, the following mechanism is proposed. LaC is dissolved in gastric juice and absorbed into the gastric mucosa. The absorbed La is crystalized in the alkaline environment in the mucosa, and then the crystals are covered by proteinous material. They are phagocytized by histiocytes, occasionally together with other materials, such as hemosiderin and collagen fibers. Finally, some histiocytes migrate to regional lymph nodes. This process is suggestive of pneumoconiosis of the lung. Duodenal lesions, which have a less acidic environment, are rare or predominantly located in the bulbus.
The progression and outcome of gastric lanthanosis remain unknown. To date, serious signs and symptoms related to gastric lanthanosis have not been reported. Follow-up data after stopping administration of LaC was described in three patients. 8, 9 In these reports, La deposi- been documented in gastric lanthanosis. It is unclear whether La deposition does not induce fibrosis or whether the LaC-dosing period is too short to develop fibrosis. It is also possible that histiocytes in gastric lanthanosis migrate to regional lymph nodes without leaving any fibrosis. There were several limitations to this study. The number of cases was not large enough for a robust analysis. There were no long-term follow-up data on the outcomes of continuing or stopping LaC treatment after a definite diagnosis of gastric lanthanosis.
In conclusion, we described an under-recognized lesion, "gastric lanthanosis." This lesion is not rare and is characterized by endoscopic BWS and histological eosinophilic histiocytes in the gastric mucosa of dialysis patients treated with LaC. 
